KDM4B and glioblastoma: In line with the above results, U87-MG and LN229 cells with KDM4B silencing generated much smaller tumors in immunodeficient mice than the control cells (Fig. 3C, D), indicating that KDM4B silencing suppressed the tumorigenicity of GBM cells.